Ionis Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
CEOBrett P. Monia
CEOBrett P. Monia
Employees1,069
Employees1,069
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded1989
Founded1989
Employees1,069
Employees1,069
IONS Key Statistics
Market cap10.44B
Market cap10.44B
Price-Earnings ratio-34.64
Price-Earnings ratio-34.64
Dividend yield—
Dividend yield—
Average volume2.00M
Average volume2.00M
High today$65.55
High today$65.55
Low today$63.66
Low today$63.66
Open price$63.86
Open price$63.86
Volume1.39M
Volume1.39M
52 Week high$65.55
52 Week high$65.55
52 Week low$23.95
52 Week low$23.95
IONS News
Simply Wall St 3d
Is Ionis Pharmaceuticals Still Attractive After 85% Rally and ALS Drug Approval?If you have been watching Ionis Pharmaceuticals lately, you are definitely not alone. The stock is having quite the run, up 5% in the past week and nearly 50% i...
TipRanks 4d
Ionis Pharmaceuticals upgraded to Neutral from Sell at Goldman SachsGoldman Sachs analyst Salveen Richter upgraded Ionis Pharmaceuticals (IONS) to Neutral from Sell with a price target of $65, up from $45. The firm says Ionis is...
Analyst ratings
74%
of 27 ratingsBuy
74.1%
Hold
25.9%
Sell
0%
People also own
Based on the portfolios of people who own IONS. This list is generated using Robinhood data, and it’s not a recommendation.